Corrigendum to "The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease"
- PMID: 32328144
- PMCID: PMC7171459
- DOI: 10.1155/2020/9575878
Corrigendum to "The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease"
Abstract
[This corrects the article DOI: 10.1155/2018/1751583.].
Copyright © 2020 John E. Lewis et al.
Conflict of interest statement
John E. Lewis has been paid by Daiwa Pharmaceutical to speak at international conferences and write articles on health and wellness for their website. Steven E. Atlas, Oscar L. Higuera, Andrea Fiallo, Ammar Rasul, Ashar Farooqi, Olga Kromo, Laura A. Lantigua, Eduard Tiozzo, Judi M. Woolger, Sharon Goldberg, Armando Mendez, Allan Rodriguez, and Janet Konefal have no conflicts of interests.
Erratum for
-
The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease.Evid Based Complement Alternat Med. 2018 May 3;2018:1751583. doi: 10.1155/2018/1751583. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 29853945 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
